In HCC, activation of the IL‐6/STAT3 pathway directly enhances the expression of TIMP‐1 in liver cancer cells, converting normal hepatic fibroblasts to cancer‐associated fibroblasts, thus altering the tumour microenvironment and promoting tumourigenesis. The gene discussed is STAT3; the disease is neoplasm.